Market Place
Sourcing Support
Immusoft To Announce Phase 1 Engineered B Cell Therapy Data
23 Sep 2024 //
PR NEWSWIRE
Immusoft To Present on ISP-001 Clinical Trial at WORLDSymposium™ 2024 Conference
03 Jan 2024 //
BUSINESSWIRE
Immusoft Administers the First Engineered B Cell in a Human Clinical Trial
15 Dec 2023 //
BUSINESSWIRE
In a first, Immusoft gives engineered B cell in a clinical trial
15 Dec 2023 //
FIERCE BIOTECH
Immusoft Acquires Rights to Property for Genome Edited Primary B Cells
27 Mar 2023 //
BUSINESSWIRE
Immusoft Awarded $8M in Funding from the CIRM for MPS I Clinical Program
27 Jan 2023 //
BUSINESSWIRE
Immusoft Announces FDA Clearance of IND Application for ISP-001 for MPS I
01 Sep 2022 //
BUSINESSWIRE
Immusoft and Takeda to develop cell therapies for rare metabolic disorders
14 Oct 2021 //
PHARMACEUTICAL-TECHNOLOGY
Takeda inks another biobucks pact: $900M for Immusoft`s B cells
14 Oct 2021 //
FIERCEBIOTECH
Immusoft Announces Formation of Scientific Advisory Board
23 Jun 2021 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.